Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
anti-sense oligo
Biotech
After 11-month romance, GSK buys oligonucleotide partner Elsie
After taking 11 months to get to know Elsie and its oligonucleotide platform, the Big Pharma has bought the West Coast biotech for up to $50 million.
Nick Paul Taylor
Jun 6, 2024 9:41am
Creyon collects $40M to create 'on demand' RNA-based medicines
Mar 8, 2022 10:00am
BMS, VCs back Ceptur with $75M for RNA meds to silence pre-mRNA
Jan 19, 2022 7:00am
Takeda crashes out of Wave discovery pact at cost of $23M
Oct 20, 2021 8:10am
PepGen raises $113M to challenge Sarepta in DMD
Aug 5, 2021 7:00am
Ionis pays $45M to expand oligonucleotide delivery toolkit
Jul 13, 2021 8:20am
